AXOVANT GENE THERAPIES LTD

CUSIP: G0750W203 Class: COM

GEODE CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001214717)

Note: Option positions (PUT/CALL) are excluded.

Q3 2020
Shares 23,058 Value ($000) $106 Avg Close — Range —
Q2 2020
Shares 58,313 Value ($000) $164 Avg Close — Range —
Q1 2020
Shares 44,225 Value ($000) $107 Avg Close — Range —
Q4 2019
Shares 35,847 Value ($000) $183 Avg Close — Range —
Q3 2019
Shares 20,115 Value ($000) $129 Avg Close — Range —
Q2 2019
Shares 20,115 Value ($000) $125 Avg Close — Range —